In the CLASSIC study, capecitabine–oxaliplatin was an effective chemotherapy after D2 gastrectomy for stage II–IIIB gastric cancer. We compared these data with the ACTS-GC study, which was the only pivotal study proving the benefit of adjuvant chemotherapy in these patients. Long-term survival data from CLASSIC are awaited with interest.boxed-text
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Preoperative Platelet-Lymphocyte Ratio (PLR) as a prognostic inflammation biomarker in Asian HIV-infected patients with gastric cancer: a single-center study
BMC Gastroenterology Open Access 26 May 2023
-
Hepatectomy for liver metastases from gastric cancer: a systematic review
BMC Surgery Open Access 13 February 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
15 March 2012
In the version of this article initially published online the data for survival in the ACTS-GC trial were incorrect in Table 1. The 3-year RFS should be 72.2% vs 59.6% and the 3-year OS should be 80.1% vs 70.1%. The error has been corrected for the print, HTML and PDF versions of the article.
References
Macdonald, J. S. et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N. Engl. J. Med. 345, 725–730 (2001).
Cunningham, D. et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med. 355, 11–20 (2006).
Sasako, M. et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J. Clin. Oncol. 29, 4387–4393 (2011).
Hundahl, S. A. et al. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann. Surg. Oncol. 9, 278–86 (2002).
Wu, C. W. et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol. 7, 309–315 (2006).
Okines, A. et al. Gastric Cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 21 (Suppl. 5), v50–v54 (2010).
NCCN. NCCN Clinical Practice Guidelines in Oncology. Gastric Cancer Version 2.2011 [online], (2011).
Bang, Y. J. et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 379, 315–321 (2012).
Macdonald, J. S. Gastric cancer: Nagoya is not New York. J. Clin. Oncol. 29, 4348–4350 (2011).
Lee, J. Y. et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: The ARTIST trial. J. Clin. Oncol. 30, 268–273 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M. Sasako is a consultant for and receives honoraria and grant support from Chugai Pharmaceuticals and Taiho Pharmaceuticals. M. Sasako also receives honoraria and grant support from Sanofi-Aventis. T. Yoshikawa declares no competing interests.
Rights and permissions
About this article
Cite this article
Yoshikawa, T., Sasako, M. Adjuvant chemotherapy after D2 gastrectomy for gastric cancer. Nat Rev Clin Oncol 9, 192–194 (2012). https://doi.org/10.1038/nrclinonc.2012.23
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2012.23
This article is cited by
-
Preoperative Platelet-Lymphocyte Ratio (PLR) as a prognostic inflammation biomarker in Asian HIV-infected patients with gastric cancer: a single-center study
BMC Gastroenterology (2023)
-
Clinicopathological Characteristics and Incidence of Gastric Cancer in Eastern India: A Retrospective Study
Journal of Gastrointestinal Cancer (2021)
-
Hepatectomy for liver metastases from gastric cancer: a systematic review
BMC Surgery (2017)
-
Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302)
Gastric Cancer (2016)
-
Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy
Surgery Today (2014)